QIAGEN

We are excited to announce a new collaboration with NVIDIA to advance AI-driven drug discovery. Learn more 👉 https://lnkd.in/eKW8K8Gw Drug discovery depends on connecting complex biological data across genes, diseases, pathways, compounds and clinical evidence. Together with NVIDIA Healthcare, we are combining QIAGEN Digital Insights' curated biomedical knowledge bases with the NVIDIA BioNeMo platform to help researchers get from data to discovery decisions faster. Here's what this collaboration brings to the bench: ✅ Integrate NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights' curated biomedical knowledge bases ✅ Jointly advance how disease mechanisms, therapeutic targets and biomarkers are identified ✅ Explore mechanisms, therapeutic targets and biomarkers with greater speed, context and confidence using a graph-based AI approach ✅ Join initial pilot programs available to select pharmaceutical and biotechnology partners, with broader availability in future stages following validation

May is International Nurses Month – a time to recognize the essential role nurses play in stopping the spread and progression of tuberculosis (TB). This Nurses Month, strengthen your knowledge of TB infection testing by watching this on-demand webinar before May 31 ➡️ https://lnkd.in/ew2JCg4U   It often begins with a single patient, and the difference between missing tuberculosis (TB) and catching it early comes down to knowledge. In this course, you’ll explore the global impact of TB, evolving testing guidelines and how to identify patients at higher risk. You’ll also learn how modern blood-based testing, including QuantiFERON-TB Gold Plus, supports TB control, all while you earn CEU credits (for US-based nurses). Because stopping TB starts with the healthcare professional who knows when to test. #NursesMonth #QIAGENCelebratesNurses #TBawareness #PublicHealth #QuantiFERON 

We're excited to share that our newly launched QIAsprint Connect has received the prestigious Red Dot Design Award, marking the fifth time a QIAGEN instrument has earned this global recognition.   ✅ QIAsprint Connect delivers high-throughput nucleic acid extraction with up to 192 samples per run, all in a compact benchtop footprint. With built-in decontamination control, validated and customizable protocols accessible via an intuitive touchscreen and digital connectivity for remote run monitoring, it helps labs maximize walk-away efficiency and ease of use.   ✅ It also introduces a novel consumables concept that reduces plastic use by up to 50% and packaging volume by 40% compared to standard market consumables, helping labs scale more sustainably without compromising performance.   The Red Dot jury recognized QIAsprint Connect for its user-centric functionality and design, reflecting how modern lab instruments should integrate into increasingly digital, high-throughput environments.   This award reinforces our commitment to solutions that don't just fit on your lab bench but also perform better and elevate the everyday lab experience.

Targeted sequencing plays a critical role in advancing precision oncology – but optimizing workflows and selecting the right approach can be complex. Join our Targeted Sequencing Focus Day, an event designed to help you: ✅ Optimize targeted DNA and RNA sequencing workflows ✅ Overcome common sequencing bottlenecks ✅ Select the right approach for your lab’s goals Gain practical insights into improving efficiency, data quality, and flexibility – all supported by QIAseq NGS technologies. Save your seat for this free online event 👉https://lnkd.in/eemwzeWB #PrecisionOncology #NGS #DNAseq #RNAseq #CGP #HRD

We are excited to announce two major innovations coming to QuantiFERON latent TB testing: a fully automated Sample to Insight workflow and an AI-enabled risk stratification tool, both targeted for late 2027. Learn more 👉 https://lnkd.in/dsZSjmbx As TB screening volumes continue to grow, high-throughput laboratories need solutions that scale efficiently. Here's what's coming: ✅ A fully automated end-to-end workflow integrating QuantiFERON, Diasorin LIAISON systems and purpose-built automation through our new Inpeco partnership ✅ An AI-enabled risk stratification tool for TB progression designed to support informed clinical decision-making for all QuantiFERON customers ✅ New QuantiFERON LIAISON chemistry developed by Diasorin being rolled out to customers, delivering significant throughput and workflow benefits

If TB infection testing is part of your daily practice, you can’t miss this. Our free interactive e-book walks you through how to identify risk groups, choose the right test and improve testing accuracy using QuantiFERON-TB Gold Plus. Download your copy here: https://lnkd.in/d-ugZz8F You’ll get clear, evidence-based recommendations to help you: ✅ Focus on the patients who need testing most – from recent immigrants and healthcare workers to children, dialysis patients and those on immunosuppressive therapy. Intervene before infection progresses. ✅ Confidently choose between TST and IGRA – with a simple breakdown of accuracy, BCG impact and workflow differences. Make testing decisions with clarity. ✅ Align with trusted guidance – bringing CDC, ATS, IDSA and WHO recommendations together in one place. Keep screening and follow-up aligned with best practices. Because early and accurate TB infection detection has the power to change outcomes.

Digital PCR takes forever and is super complicated. You can be on either team NGS or dPCR. qPCR has been around for ages, so it’s more trustworthy. Heard some of these before, but questioned their validity🤔? Then you might be interested in our list of common dPCR myths, assembled only to be disassembled in the quest for dPCR justice⚖️. Check out the very real dPCR misconceptions our team encounters in labs across the world. And see how our experts would answer if they had a loudspeaker📢 loud enough to reach all dPCR current and potential users. #DigitalPCR #dPCR #qPCR #Multiplex #GeneExpression 

What if clinical labs could increase their syndromic testing capabilities without adding additional complexity? We’ve made that possible with our fully automated, high-throughput syndromic testing platform, QIAstat-Dx Rise. An expanded testing menu, now including FDA-cleared gastrointestinal (GI) panels, enables labs to consolidate both respiratory (RP) and GI pathogen testing into a single platform for comprehensive disease insights. What does this mean for your lab? ✅   Accurate detection of the most clinically-relevant RP and GI pathogens ✅  Testing flexibility with access to both extended and targeted syndromic panels  ✅  True walkaway freedom due to minimal hands-on time  ✅  Results in about an hour to support timely clinical decisions Discover how QIAstat Dx-Rise can transform gastrointestinal care. ➡️ https://lnkd.in/ehDgriJz

How many steps in your cell and gene therapy (CGT) workflow are you truly confident in and how many are you just hoping will work? In cell and gene therapy development, your workflow needs to deliver every step of the way. At ISCT 2026 (May 6-9, Dublin), explore how automation and digital PCR can help you improve consistency, reduce variability and move forward with confidence. 🔬 QIAsprint® Connect: Automated high-throughput nucleic acid extraction system that offers compliance-ready flexibility for downstream molecular analysis 📊 QIAcuity® Digital PCR: Precise, reproducible quantification for CGT analytics, enabling confident assessment of critical quality attributes 📍 Booth 1908 🎤 May 7 | Global Showcase presentation on CAR T analytics presented by Anida Mesihovic Karamitsos, PhD (QIAGEN) and Arvind M Padma, PhD (CCRM Nordic)

Happy DNA Day!   Let’s take a moment to celebrate all the amazing things we’ve achieved with this molecule. Like improving detection and treatment of disease, analyzing plant genomes, catching criminals, sequencing ancient DNA from mammoths, investigating microbiomes, testing food safety and even using DNA to store data.   How familiar are you with all of these achievements? Pick your brain in a fun game of three truths and a lie and try to identify the incorrect DNA fact below.   And here’s one more fact...We, at QIAGEN, have been working with DNA for 40 years. In this time, we’ve put together DNA extraction kits that are recognized, used and loved by researchers all over the world. Interested in testing some of these as trial kits during our DNA Day special? Build on celebration and find out more ➡️ https://lnkd.in/dMkbU7hD